Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Laboratory Services

 

Apax enters race for Synlab

Rothschild and BC Partners have infuriated private equity bidders for Synlabs by allowing Apax-owned Unilabs to enter the bidding for the Pan-European lab group.

FREE BLOG Who really makes money out of labs?

Blaise Mentha, Jean-Louis Oger, Eric Souetre - it is striking how charismatic entrepreneurs serially trouser millions from diagnostic labs. It is much harder for private equity to make money from lab groups. Why? And does the same hold true for other healthcare sectors?

Hassab Labs looks to catch up with IDH

Egypt’s third largest lab group, Hassab Labs, is targeting North Africa as it ramps up its expansion plans. CEO Mohamed Azab says a partnership with the pan-African, Saham Insurance, will provide opportunities there and across the rest of the continent. But is it too late?

All change in the French lab space

Biomnis and Bio-Access are both close to getting new owners. That will herald the arrival on the scene of a major quoted industrial.

Amedes could sell fast

We hear talks to sell German/Belgian lab group amedes are far advanced, and not to private equity.

Interview: Dr Peter Cole, managing partner at Lancet Laboratories

South African diagnostic lab group Lancet is consolidating the African lab market, expanding into 12 countries in 12 years. We speak to managing partner, Dr Peter Cole, about the South African healthcare services market generally, the different African markets and the challenge posed by European and Indian competitors.

Eurofins for Biomnis?

Biomnis, one of the two large French reference labs, could be bought by Eurofins, which claims to be the world leader in food and environmental lab services. Eurofins, which is quoted, is one of two remaining bidders, according to a French news report.

Cinven scoops Labco (revised story)

Private equity house Cinven is to buy Labco for an enterprise value of just €1.2bn. The news came two weeks after Labco’s IPO failed. We reflect here on the EBITDA multiple and at what this means for the rationalisation of the European market. Who will Cinven buy next?

Cinven scoops Labco at silly price

Private equity house Cinven is to buy Labco for an enterprise value of just €1.2bn. The news came two weeks after Labco’s IPO failed. We reflect here on the EBITDA multiple and at what this means for the rationalisation of the European market.

Find Us